
### [MONDO:0017897](http://purl.obolibrary.org/obo/MONDO_0017897)
**Label:** autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency

**Subclasses:** [MONDO:0013955](http://purl.obolibrary.org/obo/MONDO_0013955) (mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency), [MONDO:0020530](http://purl.obolibrary.org/obo/MONDO_0020530) (mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency), [MONDO:0014710](http://purl.obolibrary.org/obo/MONDO_0014710) (autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency), [MONDO:0014502](http://purl.obolibrary.org/obo/MONDO_0014502) (mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency), [MONDO:0017900](http://purl.obolibrary.org/obo/MONDO_0017900) (mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency), [MONDO:0013954](http://purl.obolibrary.org/obo/MONDO_0013954) (mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency), 

**Mapped go classes:** [GO:0042019](http://purl.obolibrary.org/obo/GO_0042019) (interleukin-23 binding), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0098531](http://purl.obolibrary.org/obo/GO_0098531) (transcription factor activity, direct ligand regulated sequence-specific DNA binding), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0032922](http://purl.obolibrary.org/obo/GO_0032922) (circadian regulation of gene expression), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0070244](http://purl.obolibrary.org/obo/GO_0070244) (negative regulation of thymocyte apoptotic process), [GO:0042020](http://purl.obolibrary.org/obo/GO_0042020) (interleukin-23 receptor activity), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0016517](http://purl.obolibrary.org/obo/GO_0016517) (interleukin-12 receptor activity), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0010906](http://purl.obolibrary.org/obo/GO_0010906) (regulation of glucose metabolic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0072539](http://purl.obolibrary.org/obo/GO_0072539) (T-helper 17 cell differentiation), [GO:0019955](http://purl.obolibrary.org/obo/GO_0019955) (cytokine binding), [GO:0072615](http://purl.obolibrary.org/obo/GO_0072615) (interleukin-17 secretion), [GO:0036315](http://purl.obolibrary.org/obo/GO_0036315) (cellular response to sterol), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0048537](http://purl.obolibrary.org/obo/GO_0048537) (mucosal-associated lymphoid tissue development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0045586](http://purl.obolibrary.org/obo/GO_0045586) (regulation of gamma-delta T cell differentiation), [GO:0046632](http://purl.obolibrary.org/obo/GO_0046632) (alpha-beta T cell differentiation), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042753](http://purl.obolibrary.org/obo/GO_0042753) (positive regulation of circadian rhythm), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0048541](http://purl.obolibrary.org/obo/GO_0048541) (Peyer's patch development), [GO:0032620](http://purl.obolibrary.org/obo/GO_0032620) (interleukin-17 production), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0060850](http://purl.obolibrary.org/obo/GO_0060850) (regulation of transcription involved in cell fate commitment), [GO:0033077](http://purl.obolibrary.org/obo/GO_0033077) (T cell differentiation in thymus), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0005143](http://purl.obolibrary.org/obo/GO_0005143) (interleukin-12 receptor binding), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0045598](http://purl.obolibrary.org/obo/GO_0045598) (regulation of fat cell differentiation), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0042093](http://purl.obolibrary.org/obo/GO_0042093) (T-helper cell differentiation), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0048511](http://purl.obolibrary.org/obo/GO_0048511) (rhythmic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0019218](http://purl.obolibrary.org/obo/GO_0019218) (regulation of steroid metabolic process), 

**Class expressions from DL-Learner:**

- [GO:0042020](http://purl.obolibrary.org/obo/GO_0042020) (interleukin-23 receptor activity) 53.33%
- [GO:0016517](http://purl.obolibrary.org/obo/GO_0016517) (interleukin-12 receptor activity) 53.33%
- [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding) 53.33%
- [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity) 53.33%
- [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity) 53.33%
- Thing 52.48%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) 38.69%
- [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding) 38.69%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 38.69%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 38.69%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 38.69%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 38.69%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 38.69%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 38.69%
- [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 38.69%


